Evasion of adaptive and innate immune response mechanisms by γ-herpesviruses

Current Opinion in Virology

Volumn 3, Issue 3, 2013, Pages 285-295

  Feng, Pinghui ^a   Moses, Ashlee ^b   Früh, Klaus ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BECLIN 1; BETA INTERFERON; CASPASE 3; E1A ASSOCIATED P300 PROTEIN; EPITOPE; INTERCELLULAR ADHESION MOLECULE 1; INTERFERON REGULATORY FACTOR; INTERFERON REGULATORY FACTOR 1; INTERFERON REGULATORY FACTOR 3; INTERFERON REGULATORY FACTOR 5; INTERFERON REGULATORY FACTOR 7; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; INTERLEUKIN 6; PROTEIN; PROTEIN BCL 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; UBIQUITIN PROTEIN LIGASE E3;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTATION; ANTIGENICITY; APOPTOSIS; ARTICLE; AUTOPHAGY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CYTOKINE PRODUCTION; DNA DAMAGE; DOWN REGULATION; GAMMAHERPESVIRINAE; GENE EXPRESSION; HUMAN; IMMUNE EVASION; IMMUNE RESPONSE; INFECTION; INNATE IMMUNITY; INTERFERON PRODUCTION; LATENT VIRUS INFECTION; LYMPHOCYTE ACTIVATION; MACROPHAGE ACTIVATION; MITOCHONDRIAL MEMBRANE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RNA TRANSLATION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TRANSLATION INITIATION; UBIQUITINATION; VIRUS LATENCY; VIRUS REACTIVATION; VIRUS REPLICATION;

EID: 84880288803     PISSN: 18796257     EISSN: 18796265     Source Type: Journal    
DOI: 10.1016/j.coviro.2013.05.011     Document Type: Review

References (144)

1. M.L. Freeman, K.G. Lanzer, T. Cookenham, B. Peters, and J. Sidney Two kinetic patterns of epitope-specific CD8 T-cell responses following murine gammaherpesvirus 68 infection J Virol 84 2010 2881 2892
2. S. Gredmark-Russ, E.J. Cheung, M.K. Isaacson, H.L. Ploegh, and Grotenbreg GM The CD8 T-cell response against murine gammaherpesvirus 68 is directed toward a broad repertoire of epitopes from both early and late antigens J Virol 82 2008 12205 12212
3. S. Marques, M. Alenquer, P.G. Stevenson, and Simas JP A single CD8+ T cell epitope sets the long-term latent load of a murid herpesvirus PLoS Pathog 4 2008 e1000177
4. N.J. Bennett, J.S. May, and Stevenson PG Gamma-herpesvirus latency requires T cell evasion during episome maintenance PLoS Biol 3 2005 e120
5. Blake N Immune evasion by gammaherpesvirus genome maintenance proteins J Gen Virol 91 2010 829 846
6. T. Vider-Shalit, V. Fishbain, S. Raffaeli, and Louzoun Y Phase-dependent immune evasion of herpesviruses J Virol 81 2007 9536 9545
7. J. Levitskaya, A. Sharipo, A. Leonchiks, A. Ciechanover, and Masucci MG Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1 Proc Natl Acad Sci USA 94 1997 12616 12621
8. C. Daskalogianni, S. Apcher, M.M. Candeias, N. Naski, and F. Calvo Gly-Ala repeats induce position- and substrate-specific regulation of 26 S proteasome-dependent partial processing J Biol Chem 283 2008 30090 30100
9. S. Apcher, A. Komarova, C. Daskalogianni, Y. Yin, and L. Malbert-Colas mRNA translation regulation by the Gly-Ala repeat of Epstein-Barr virus nuclear antigen 1 J Virol 83 2009 1289 1298
10. S. Apcher, C. Daskalogianni, B. Manoury, and Fahraeus R Epstein Barr virus-encoded EBNA1 interference with MHC class I antigen presentation reveals a close correlation between mRNA translation initiation and antigen presentation PLoS Pathog 6 2010 e1001151
11. Y. Yin, B. Manoury, and Fahraeus R Self-inhibition of synthesis and antigen presentation by Epstein-Barr virus-encoded EBNA1 Science 301 2003 1371 1374
12. J. Tellam, C. Smith, M. Rist, N. Webb, and L. Cooper Regulation of protein translation through mRNA structure influences MHC class I loading and T cell recognition Proc Natl Acad Sci USA 105 2008 9319 9324
13. H.J. Kwun, S.R. da Silva, I.M. Shah, N. Blake, and P.S. Moore Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mimics Epstein-Barr virus EBNA1 immune evasion through central repeat domain effects on protein processing J Virol 81 2007 8225 8235
14. A. Zaldumbide, M. Ossevoort, E.J. Wiertz, and Hoeben RC In cis inhibition of antigen processing by the latency-associated nuclear antigen I of Kaposi sarcoma herpes virus Mol Immunol 44 2007 1352 1360
15. H.J. Kwun, S.R. da Silva, H. Qin, R.L. Ferris, and R. Tan The central repeat domain 1 of Kaposi's sarcoma-associated herpesvirus (KSHV) latency associated-nuclear antigen 1 (LANA1) prevents cis MHC class I peptide presentation Virology 412 2011 357 365
16. J. Gao, J.M. Coulson, A. Whitehouse, and Blake N Reduction in RNA levels rather than retardation of translation is responsible for the inhibition of major histocompatibility complex class I antigen presentation by the glutamic acid-rich repeat of herpesvirus saimiri open reading frame 73 J Virol 83 2009 273 282
17. M.E. Ressing, D. Horst, B.D. Griffin, J. Tellam, and J. Zuo Epstein-Barr virus evasion of CD8(+) and CD4(+) T cell immunity via concerted actions of multiple gene products Semin Cancer Biol 18 2008 397 408
18. N.P. Croft, C. Shannon-Lowe, A.I. Bell, D. Horst, and E. Kremmer Stage-specific inhibition of MHC class I presentation by the Epstein-Barr virus BNLF2a protein during virus lytic cycle PLoS Pathog 5 2009 e1000490
19. D. Horst, D. van Leeuwen, N.P. Croft, M.A. Garstka, and A.D. Hislop Specific targeting of the EBV lytic phase protein BNLF2a to the transporter associated with antigen processing results in impairment of HLA class I-restricted antigen presentation J Immunol 182 2009 2313 2324
20. A.D. Hislop, M.E. Ressing, D. van Leeuwen, V.A. Pudney, and D. Horst A CD8+ T cell immune evasion protein specific to Epstein-Barr virus and its close relatives in Old World primates J Exp Med 204 2007 1863 1873
21. S. Jochum, A. Moosmann, S. Lang, W. Hammerschmidt, and Zeidler R The EBV immunoevasins vIL-10 and BNLF2a protect newly infected B cells from immune recognition and elimination PLoS Pathog 8 2012 e1002704
22. A.I. Wycisk, J. Lin, S. Loch, K. Hobohm, and J. Funke Epstein-Barr viral BNLF2a protein hijacks the tail-anchored protein insertion machinery to block antigen processing by the transport complex TAP J Biol Chem 286 2011 41402 41412
23. D. Horst, V. Favaloro, F. Vilardi, H.C. van Leeuwen, and M.A. Garstka EBV protein BNLF2a exploits host tail-anchored protein integration machinery to inhibit TAP J Immunol 186 2011 3594 3605
24. J. Zuo, L.L. Quinn, J. Tamblyn, W.A. Thomas, and R. Feederle The Epstein-Barr virus-encoded BILF1 protein modulates immune recognition of endogenously processed antigen by targeting major histocompatibility complex class I molecules trafficking on both the exocytic and endocytic pathways J Virol 85 2011 1604 1614
25. J. Zuo, A. Currin, B.D. Griffin, C. Shannon-Lowe, and W.A. Thomas The Epstein-Barr virus G-protein-coupled receptor contributes to immune evasion by targeting MHC class I molecules for degradation PLoS Pathog 5 2009 e1000255
26. J.M. Boname, and Lehner PJ What has the study of the K3 and K5 viral ubiquitin E3 ligases taught us about ubiquitin-mediated receptor regulation? Viruses 3 2011 118 131
27. J.A. Nathan, and Lehner PJ The trafficking and regulation of membrane receptors by the RING-CH ubiquitin E3 ligases Exp Cell Res 315 2009 1593 1600
28. S. Harris, S.M. Lang, and Means RE Characterization of the rhesus fibromatosis herpesvirus MARCH family member rfK3 Virology 398 2010 214 223
29. M. Thomas, M. Wills, and Lehner PJ Natural killer cell evasion by an E3 ubiquitin ligase from Kaposi's sarcoma-associated herpesvirus Biochem Soc Trans 36 2008 459 463
30. R. Karki, S.M. Lang, and Means RE The MARCH family E3 ubiquitin ligase K5 alters monocyte metabolism and proliferation through receptor tyrosine kinase modulation PLoS Pathog 7 2011 e1001331
31. M. Mansouri, K. Viswanathan, J.L. Douglas, J. Hines, and J. Gustin Molecular mechanism of BST2/tetherin downregulation by K5/MIR2 of Kaposi's sarcoma-associated herpesvirus J Virol 83 2009 9672 9681
32. P.G. Stevenson, J.S. May, X.G. Smith, S. Marques, and H. Adler K3-mediated evasion of CD8(+) T cells aids amplification of a latent gamma-herpesvirus Nat Immunol 3 2002 733 740
33. J. Loh, D.L. Popkin, L. Droit, D.C. Braaten, and G. Zhao Specific mutation of a gammaherpesvirus-expressed antigen in response to CD8 T cell selection in vivo J Virol 86 2012 2887 2893
34. M.L. Freeman, C.E. Burkum, K.G. Lanzer, M.K. Jensen, and M. Ahmed Cutting edge: activation of virus-specific CD4 T cells throughout gamma-herpesvirus latency J Immunol 187 2011 6180 6184
35. J. Myoung, and Ganem D Active lytic infection of human primary tonsillar B cells by KSHV and its noncytolytic control by activated CD4+ T cells J Clin Invest 121 2011 1130 1140
36. K.A. Stuller, and Flano E CD4 T cells mediate killing during persistent gammaherpesvirus 68 infection J Virol 83 2009 4700 4703
37. K. Schmidt, E. Wies, and Neipel F Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 3 inhibits gamma interferon and major histocompatibility complex class II expression J Virol 85 2011 4530 4537
38. S. Sabbah, Y.J. Jagne, J. Zuo, T. de Silva, and M.M. Ahasan T-cell immunity to Kaposi sarcoma-associated herpesvirus: recognition of primary effusion lymphoma by LANA-specific CD4+ T cells Blood 119 2012 2083 2092
39. J. Zuo, W.A. Thomas, T.A. Haigh, L. Fitzsimmons, and H.M. Long Epstein-Barr virus evades CD4+ T cell responses in lytic cycle through BZLF1-mediated downregulation of CD74 and the cooperation of vBcl-2 PLoS Pathog 7 2011 e1002455
40. L.M. Butler, H.C. Jeffery, R.L. Wheat, H.M. Long, and P.C. Rae Kaposi's sarcoma-associated herpesvirus inhibits expression and function of endothelial cell major histocompatibility complex class II via suppressor of cytokine signaling 3 J Virol 86 2012 7158 7166
41. S.M. Gregory, L. Wang, J.A. West, D.P. Dittmer, and Damania B Latent Kaposi's sarcoma-associated herpesvirus infection of monocytes downregulates expression of adaptive immune response costimulatory receptors and proinflammatory cytokines J Virol 86 2012 3916 3923
42. C. Liang, and E.X. Jung JU Downregulation of autophagy by herpesvirus Bcl-2 homologs Autophagy 4 2008 268 272
43. M. Djerbi, V. Screpanti, A.I. Catrina, B. Bogen, and P. Biberfeld The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors J Exp Med 190 1999 1025 1032
44. P.M. Chaudhary, A. Jasmin, M.T. Eby, and L. Hood Modulation of the NF-kappa B pathway by virally encoded death effector domains-containing proteins Oncogene 18 1999 5738 5746
45. I. Guasparri, S.A. Keller, and Cesarman E KSHV vFLIP is essential for the survival of infected lymphoma cells J Exp Med 199 2004 993 1003
46. S.A. Keller, E.J. Schattner, and Cesarman E Inhibition of NF-kappaB induces apoptosis of KSHV-infected primary effusion lymphoma cells Blood 96 2000 2537 2542
47. H. Matta, and Chaudhary PM Activation of alternative NF-kappa B pathway by human herpes virus 8-encoded Fas-associated death domain-like IL-1 beta-converting enzyme inhibitory protein (vFLIP) Proc Natl Acad Sci USA 101 2004 9399 9404
48. P. Chugh, H. Matta, S. Schamus, S. Zachariah, and A. Kumar Constitutive NF-kappaB activation, normal Fas-induced apoptosis, and increased incidence of lymphoma in human herpes virus 8 K13 transgenic mice Proc Natl Acad Sci USA 102 2005 12885 12890
49. Q. Sun, H. Matta, and Chaudhary PM The human herpes virus 8-encoded viral FLICE inhibitory protein protects against growth factor withdrawal-induced apoptosis via NF-kappa B activation Blood 101 2003 1956 1961
50. G. Ballon, K. Chen, R. Perez, W. Tam, and Cesarman E Kaposi sarcoma herpesvirus (KSHV) vFLIP oncoprotein induces B cell transdifferentiation and tumorigenesis in mice J Clin Invest 121 2011 1141 1153
51. C. Grossmann, S. Podgrabinska, M. Skobe, and Ganem D Activation of NF-kappaB by the latent vFLIP gene of Kaposi's sarcoma-associated herpesvirus is required for the spindle shape of virus-infected endothelial cells and contributes to their proinflammatory phenotype J Virol 80 2006 7179 7185
52. D. Glykofrydes, H. Niphuis, E.M. Kuhn, B. Rosenwirth, and J.L. Heeney Herpesvirus saimiri vFLIP provides an antiapoptotic function but is not essential for viral replication, transformation, or pathogenicity J Virol 74 2000 11919 11927
53. J.M. Hardwick, and Bellows DS Viral versus cellular BCL-2 proteins Cell Death Differ 10 suppl. 1 2003 S68 S76
54. E.H. Cheng, J. Nicholas, D.S. Bellows, G.S. Hayward, and H.G. Guo A Bcl-2 homolog encoded by Kaposi sarcoma-associated virus, human herpesvirus 8, inhibits apoptosis but does not heterodimerize with Bax or Bak Proc Natl Acad Sci USA 94 1997 690 694
55. D.S. Bellows, B.N. Chau, P. Lee, Y. Lazebnik, and W.H. Burns Antiapoptotic herpesvirus Bcl-2 homologs escape caspase-mediated conversion to proapoptotic proteins J Virol 74 2000 5024 5031
56. E.X. Hwang, S.S. Oh, J.S. Lee, and J.H. Jeong Viral Bcl-2-mediated evasion of autophagy aids chronic infection of gammaherpesvirus 68 PLoS Pathog 5 2009 e1000609
57. M. Altmann, and Hammerschmidt W Epstein-Barr virus provides a new paradigm: a requirement for the immediate inhibition of apoptosis PLoS Biol 3 2005 e404
58. P. Feng, C. Liang, Y.C. Shin, E. Xiaofei, and W. Zhang A novel inhibitory mechanism of mitochondrion-dependent apoptosis by a herpesviral protein PLoS Pathog 3 2007 e174
59. J. Friborg Jr., W. Kong, M.O. Hottiger, and Nabel GJ p53 inhibition by the LANA protein of KSHV protects against cell death Nature 402 1999 889 894
60. Q. Cai, Y. Guo, B. Xiao, S. Banerjee, and A. Saha Epstein-Barr virus nuclear antigen 3C stabilizes Gemin3 to block p53-mediated apoptosis PLoS Pathog 7 2011 e1002418
61. A. Saha, A. Bamidele, M. Murakami, and Robertson ES EBNA3C attenuates the function of p53 through interaction with inhibitor of growth family proteins 4 and 5 J Virol 85 2011 2079 2088
62. H.W. Wang, T.V. Sharp, A. Koumi, G. Koentges, and Boshoff C Characterization of an anti-apoptotic glycoprotein encoded by Kaposi's sarcoma-associated herpesvirus which resembles a spliced variant of human survivin EMBO J 21 2002 2602 2615
63. P. Feng, J. Park, B.S. Lee, S.H. Lee, and R.J. Bram Kaposi's sarcoma-associated herpesvirus mitochondrial K7 protein targets a cellular calcium-modulating cyclophilin ligand to modulate intracellular calcium concentration and inhibit apoptosis J Virol 76 2002 11491 11504
64. P. Feng, C.W. Scott, N.H. Cho, H. Nakamura, and Y.H. Chung Kaposi's sarcoma-associated herpesvirus K7 protein targets a ubiquitin-like/ubiquitin- associated domain-containing protein to promote protein degradation Mol Cell Biol 24 2004 3938 3948
65. H.R. Lee, W.C. Choi, S. Lee, J. Hwang, and E. Hwang Bilateral inhibition of HAUSP deubiquitinase by a viral interferon regulatory factor protein Nat Struct Mol Biol 18 2011 1336 1344
66. S. Pattingre, A. Tassa, X. Qu, R. Garuti, and X.H. Liang Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy Cell 122 2005 927 939
67. C. Liang, P. Feng, B. Ku, I. Dotan, and D. Canaani Autophagic and tumour suppressor activity of a novel Beclin1-binding protein UVRAG Nat Cell Biol 8 2006 688 699
68. B. Ku, J.S. Woo, C. Liang, K.H. Lee, and H.S. Hong Structural and biochemical bases for the inhibition of autophagy and apoptosis by viral BCL-2 of murine gamma-herpesvirus 68 PLoS Pathog 4 2008 e25
69. S. Sinha, C.L. Colbert, N. Becker, Y. Wei, and Levine B Molecular basis of the regulation of Beclin 1-dependent autophagy by the gamma-herpesvirus 68 Bcl-2 homolog M11 Autophagy 4 2008 989 997
70. H.R. Lee, Z. Toth, Y.C. Shin, J.S. Lee, and H. Chang Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 4 targets MDM2 to deregulate the p53 tumor suppressor pathway J Virol 83 2009 6739 6747
71. A.M. Leidal, D.P. Cyr, R.J. Hill, P.W. Lee, and McCormick C Subversion of autophagy by Kaposi's sarcoma-associated herpesvirus impairs oncogene-induced senescence Cell Host Microbe 11 2012 167 180
72. N.A. de Weerd, and T. Nguyen The interferons and their receptors - distribution and regulation Immunol Cell Biol 90 2012 483 491
73. T. Kawai, and Akira S The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors Nat Immunol 11 2010 373 384
74. J.A. West, and Damania B Kaposi's sarcoma-associated herpesvirus and innate immunity Future Virol 5 2010 185 196
75. L. Burysek, W.S. Yeow, and Pitha PM Unique properties of a second human herpesvirus 8-encoded interferon regulatory factor (vIRF-2) J Hum Virol 2 1999 19 32
76. S. Fuld, C. Cunningham, K. Klucher, A.J. Davison, and Blackbourn DJ Inhibition of interferon signaling by the Kaposi's sarcoma-associated herpesvirus full-length viral interferon regulatory factor 2 protein J Virol 80 2006 3092 3097
77. C. Areste, M. Mutocheluh, and Blackbourn DJ Identification of caspase-mediated decay of interferon regulatory factor-3, exploited by a Kaposi sarcoma-associated herpesvirus immunoregulatory protein J Biol Chem 284 2009 23272 23285
78. L. Burysek, and Pitha PM Latently expressed human herpesvirus 8-encoded interferon regulatory factor 2 inhibits double-stranded RNA-activated protein kinase J Virol 75 2001 2345 2352
79. E. Wies, A.S. Hahn, K. Schmidt, C. Viebahn, and N. Rohland The Kaposi's Sarcoma-associated herpesvirus-encoded vIRF-3 inhibits cellular IRF-5 J Biol Chem 284 2009 8525 8538
80. C.H. Joo, Y.C. Shin, M. Gack, L. Wu, and D. Levy Inhibition of interferon regulatory factor 7 (IRF7)-mediated interferon signal transduction by the Kaposi's sarcoma-associated herpesvirus viral IRF homolog vIRF3 J Virol 81 2007 8282 8292
81. S.R. Jacobs, and Damania B The viral interferon regulatory factors of KSHV: immunosuppressors or oncogenes? Front Immunol 2 2011 19
82. K. Heinzelmann, B.A. Scholz, A. Nowak, E. Fossum, and E. Kremmer Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 4 (vIRF4/K10) is a novel interaction partner of CSL/CBF1, the major downstream effector of Notch signaling J Virol 84 2010 12255 12264
83. X. Xi, L.M. Persson, M.W. O'Brien, I. Mohr, and A.C. Wilson Cooperation between viral interferon regulatory factor 4 and RTA to activate a subset of Kaposi's sarcoma-associated herpesvirus lytic promoters J Virol 86 2012 1021 1033
84. S.R. Jacobs, S.M. Gregory, J.A. West, A.C. Wollish, and D.J. Blackbourn The KSHV vIRFs differ in their inhibition of interferon activation mediated by TLR3 J Virol 87 2012 798 806
85. N. Cloutier, and Flamand L Kaposi sarcoma-associated herpesvirus latency-associated nuclear antigen inhibits interferon (IFN) beta expression by competing with IFN regulatory factor-3 for binding to IFNB promoter J Biol Chem 285 2010 7208 7221
86. S. Lefort, A. Soucy-Faulkner, N. Grandvaux, and L. Flamand Binding of Kaposi's sarcoma-associated herpesvirus K-bZIP to interferon-responsive factor 3 elements modulates antiviral gene expression J Virol 81 2007 10950 10960
87. S. Hwang, K.S. Kim, E. Flano, T.T. Wu, and L.M. Tong Conserved herpesviral kinase promotes viral persistence by inhibiting the IRF-3-mediated type I interferon response Cell Host Microbe 5 2009 166 178
88. J.T. Wang, S.L. Doong, S.C. Teng, C.P. Lee, and C.H. Tsai Epstein-Barr virus BGLF4 kinase suppresses the interferon regulatory factor 3 signaling pathway J Virol 83 2009 1856 1869
89. Q. Liang, B. Fu, F. Wu, X. Li, and Y. Yuan ORF45 of Kaposi's sarcoma-associated herpesvirus inhibits phosphorylation of interferon regulatory factor 7 by IKKepsilon and TBK1 as an alternative substrate J Virol 86 2012 10162 10172
90. N. Sathish, F.X. Zhu, E.E. Golub, Q. Liang, and Y. Yuan Mechanisms of autoinhibition of IRF-7 and a probable model for inactivation of IRF-7 by Kaposi's sarcoma-associated herpesvirus protein ORF45 J Biol Chem 286 2011 746 756
91. F.X. Zhu, S.M. King, E.J. Smith, D.E. Levy, and Y. Yuan A Kaposi's sarcoma-associated herpesviral protein inhibits virus-mediated induction of type I interferon by blocking IRF-7 phosphorylation and nuclear accumulation Proc Natl Acad Sci USA 99 2002 5573 5578
92. F.X. Zhu, N. Sathish, and Y. Yuan Antagonism of host antiviral responses by Kaposi's sarcoma-associated herpesvirus tegument protein ORF45 PLoS ONE 5 2010 e10573
93. Q. Jia, V. Chernishof, E. Bortz, I. McHardy, and T.T. Wu Murine gammaherpesvirus 68 open reading frame 45 plays an essential role during the immediate-early phase of viral replication J Virol 79 2005 5129 5141
94. Y. Yu, S.E. Wang, and Hayward GS The KSHV immediate-early transcription factor RTA encodes ubiquitin E3 ligase activity that targets IRF7 for proteosome-mediated degradation Immunity 22 2005 59 70
95. R.P. Searles, E.P. Bergquam, M.K. Axthelm, and S.W. Wong Sequence and genomic analysis of a Rhesus macaque rhadinovirus with similarity to Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 J Virol 73 1999 3040 3053
96. B.A. Robinson, R.D. Estep, I. Messaoudi, K.S. Rogers, and S.W. Wong Viral interferon regulatory factors decrease the induction of type I and type II interferon during rhesus macaque rhadinovirus infection J Virol 86 2012 2197 2211
97. B.A. Robinson, M.A. O'Connor, H. Li, F. Engelmann, and B. Poland Viral interferon regulatory factors are critical for delay of the host immune response against rhesus macaque rhadinovirus infection J Virol 86 2012 2769 2779
98. A.M. Hahn, L.E. Huye, S. Ning, J. Webster-Cyriaque, and J.S. Pagano Interferon regulatory factor 7 is negatively regulated by the Epstein-Barr virus immediate-early gene, BZLF-1 J Virol 79 2005 10040 10052
99. G.L. Bentz, R. Liu, A.M. Hahn, J. Shackelford, and J.S. Pagano Epstein-Barr virus BRLF1 inhibits transcription of IRF3 and IRF7 and suppresses induction of interferon-beta Virology 402 2010 121 128
100. L. Wu, E. Fossum, C.H. Joo, K.S. Inn, and Y.C. Shin Epstein-Barr virus LF2: an antagonist to type I interferon J Virol 83 2009 1140 1146
101. S. Ning, A.M. Hahn, L.E. Huye, and J.S. Pagano Interferon regulatory factor 7 regulates expression of Epstein-Barr virus latent membrane protein 1: a regulatory circuit J Virol 77 2003 9359 9368
102. J.M. Middeldorp, and D.M. Pegtel Multiple roles of LMP1 in Epstein-Barr virus induced immune escape Semin Cancer Biol 18 2008 388 396
103. J.E. Cameron, Q. Yin, C. Fewell, M. Lacey, and J. McBride Epstein-Barr virus latent membrane protein 1 induces cellular microRNA miR-146a, a modulator of lymphocyte signaling pathways J Virol 82 2008 1946 1958
104. N. Motsch, T. Pfuhl, J. Mrazek, S. Barth, and F.A. Grasser Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) induces the expression of the cellular microRNA miR-146a RNA Biol 4 2007 131 137
105. I. Fathallah, P. Parroche, H. Gruffat, C. Zannetti, and H. Johansson EBV latent membrane protein 1 is a negative regulator of TLR9 J Immunol 185 2010 6439 6447
106. M. van Gent, B.D. Griffin, E.G. Berkhoff, D. van Leeuwen, and I.G. Boer EBV lytic-phase protein BGLF5 contributes to TLR9 downregulation during productive infection J Immunol 186 2011 1694 1702
107. K.M. Shah, S.E. Stewart, W. Wei, C.B. Woodman, and J.D. O'Neil The EBV-encoded latent membrane proteins, LMP2A and LMP2B, limit the actions of interferon by targeting interferon receptors for degradation Oncogene 28 2009 3903 3914
108. P. Mandal, B.E. Krueger, D. Oldenburg, K.A. Andry, and R.S. Beard A gammaherpesvirus cooperates with interferon-alpha/beta-induced IRF2 to halt viral replication, control reactivation, and minimize host lethality PLoS Pathog 7 2011 e1002371
109. J. West, and B. Damania Upregulation of the TLR3 pathway by Kaposi's sarcoma-associated herpesvirus during primary infection J Virol 82 2008 5440 5449
110. D. Lagos, R.J. Vart, F. Gratrix, S.J. Westrop, and V. Emuss Toll-like receptor 4 mediates innate immunity to Kaposi sarcoma herpesvirus Cell Host Microbe 4 2008 470 483
111. S.M. Gregory, and B. Damania KSHV and the toll of innate immune activation Cell Cycle 8 2009 3246 3247
112. K.S. Inn, S.H. Lee, J.Y. Rathbun, L.Y. Wong, and Z. Toth Inhibition of RIG-I-mediated signaling by Kaposi's sarcoma-associated herpesvirus-encoded deubiquitinase ORF64 J Virol 85 2011 10899 10904
113. S.M. Gregory, B.K. Davis, J.A. West, D.J. Taxman, and S. Matsuzawa Discovery of a viral NLR homolog that inhibits the inflammasome Science 331 2011 330 334
114. V.V. Singh, N. Kerur, V. Bottero, S. Dutta, and S. Chakraborty Kaposi's sarcoma-associated herpesvirus latency in endothelial and B cells activates interferon gamma-inducible protein 16 (IFI16) mediated inflammasomes J Virol 87 2013 4417 4431
115. N. Kerur, M.V. Veettil, N. Sharma-Walia, V. Bottero, and S. Sadagopan IFI16 acts as a nuclear pathogen sensor to induce the inflammasome in response to Kaposi sarcoma-associated herpesvirus infection Cell Host Microbe 9 2011 363 375
116. L.M. Gargano, J.C. Forrest, and S.H. Speck Signaling through toll-like receptors induces murine gammaherpesvirus 68 reactivation in vivo J Virol 83 2009 1474 1482
117. X. Dong, and P. Feng Murine gamma herpesvirus 68 hijacks MAVS and IKKbeta to abrogate NFkappaB activation and antiviral cytokine production PLoS Pathog 7 2011 e1002336
118. X. Dong, H. Feng, Q. Sun, H. Li, and T.T. Wu Murine gamma-herpesvirus 68 hijacks MAVS and IKKbeta to initiate lytic replication PLoS Pathog 6 2010 e1001001
119. X. Dong, Z. He, D. Durakoglugil, L. Arneson, and Y. Shen Murine gammaherpesvirus 68 evades host cytokine production via replication transactivator-induced RelA degradation J Virol 86 2012 1930 1941
120. T. Kawai, and S. Akira Innate immune recognition of viral infection Nat Immunol 7 2006 131 137
121. H. Ahmad, R. Gubbels, E. Ehlers, F. Meyer, and T. Waterbury Kaposi sarcoma-associated herpesvirus degrades cellular Toll-interleukin-1 receptor domain-containing adaptor-inducing beta-interferon (TRIF) J Biol Chem 286 2011 7865 7872
122. J.R. Abend, D. Ramalingam, P. Kieffer-Kwon, T.S. Uldrick, and R. Yarchoan Kaposi's sarcoma-associated herpesvirus microRNAs target IRAK1 and MYD88, two components of the toll-like receptor/interleukin-1R signaling cascade, to reduce inflammatory-cytokine expression J Virol 86 2012 11663 11674
123. H.J. Martin, J.M. Lee, D. Walls, and S.D. Hayward Manipulation of the toll-like receptor 7 signaling pathway by Epstein-Barr virus J Virol 81 2007 9748 9758
124. V. Younesi, H. Nikzamir, M. Yousefi, J. Khoshnoodi, and M. Arjmand Epstein Barr virus inhibits the stimulatory effect of TLR7/8 and TLR9 agonists but not CD40 ligand in human B lymphocytes Microbiol Immunol 54 2010 534 541
125. W.H. Lim, S. Kireta, G.R. Russ, and P.T. Coates Human plasmacytoid dendritic cells regulate immune responses to Epstein-Barr virus (EBV) infection and delay EBV-related mortality in humanized NOD-SCID mice Blood 109 2007 1043 1050
126. C. Liang, J.S. Lee, and J.U. Jung Immune evasion in Kaposi's sarcoma-associated herpes virus associated oncogenesis Semin Cancer Biol 18 2008 423 436
127. T. Xia, A. O'Hara, I. Araujo, J. Barreto, and E. Carvalho EBV microRNAs in primary lymphomas and targeting of CXCL-11 by ebv-mir-BHRF1-3 Cancer Res 68 2008 1436 1442
128. R.M. Hoek, S.R. Ruuls, C.A. Murphy, G.J. Wright, and R. Goddard Down-regulation of the macrophage lineage through interaction with OX2 (CD200) Science 290 2000 1768 1771
129. M.F. Neurath, and S. Finotto IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer Cytokine Growth factor Rev 22 2011 83 89
130. H.R. Lee, S. Lee, P.M. Chaudhary, P. Gill, and J.U. Jung Immune evasion by Kaposi's sarcoma-associated herpesvirus Future Microbiol 5 2010 1349 1365
131. J. Molden, Y. Chang, Y. You, P.S. Moore, and M.A. Goldsmith A Kaposi's sarcoma-associated herpesvirus-encoded cytokine homolog (vIL-6) activates signaling through the shared gp130 receptor subunit J Biol Chem 272 1997 19625 19631
132. X. Wan, H. Wang, and J. Nicholas Human herpesvirus 8 interleukin-6 (vIL-6) signals through gp130 but has structural and receptor-binding properties distinct from those of human IL-6 J Virol 73 1999 8268 8278
133. F. Hu, and J. Nicholas Signal transduction by human herpesvirus 8 viral interleukin-6 (vIL-6) is modulated by the nonsignaling gp80 subunit of the IL-6 receptor complex and is distinct from signaling induced by human IL-6 J Virol 80 2006 10874 10878
134. C.L. Langlais, J.M. Jones, R.D. Estep, and S.W. Wong Rhesus rhadinovirus R15 encodes a functional homologue of human CD200 J Virol 80 2006 3098 3103
135. B.U. Orzechowska, M. Manoharan, J. Sprague, R.D. Estep, and M.K. Axthelm Viral interleukin-6 encoded by rhesus macaque rhadinovirus is associated with lymphoproliferative disorder (LPD) J Med Primatol 38 suppl. 1 2009 2 7
136. J.A. Kaleeba, E.P. Bergquam, and S.W. Wong A rhesus macaque rhadinovirus related to Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 encodes a functional homologue of interleukin-6 J Virol 73 1999 6177 6181
137. S. Swaminathan, R. Hesselton, J. Sullivan, and E. Kieff Epstein-Barr virus recombinants with specifically mutated BCRF1 genes J Virol 67 1993 7406 7413
138. M.T. Bejarano, and M.G. Masucci Interleukin-10 abrogates the inhibition of Epstein-Barr virus-induced B-cell transformation by memory T-cell responses Blood 92 1998 4256 4262
139. S. Salek-Ardakani, J.R. Arrand, and M. Mackett Epstein-Barr virus encoded interleukin-10 inhibits HLA-class I. ICAM-1, and B7 expression on human monocytes: implications for immune evasion by EBV Virology 304 2002 342 351
140. D.H. Hsu, R. de Waal Malefyt, D.F. Fiorentino, M.N. Dang, and P. Vieira Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1 Science 250 1990 830 832
141. L.D. Strockbine, J.I. Cohen, T. Farrah, S.D. Lyman, and F. Wagener The Epstein-Barr virus BARF1 gene encodes a novel, soluble colony-stimulating factor-1 receptor J Virol 72 1998 4015 4021
142. E. Barton, P. Mandal, and S.H. Speck Pathogenesis and host control of gammaherpesviruses: lessons from the mouse Annu Rev Immunol 29 2011 351 397
143. V. van Berkel, B. Levine, S.B. Kapadia, J.E. Goldman, and S.H. Speck Critical role for a high-affinity chemokine-binding protein in gamma-herpesvirus-induced lethal meningitis J Clin Invest 109 2002 905 914
144. D.J. Hughes, A. Kipar, G.H. Leeming, E. Bennett, and D. Howarth Chemokine binding protein M3 of murine gammaherpesvirus 68 modulates the host response to infection in a natural host PLoS Pathog 7 2011 e1001321